Literature DB >> 23997772

Reducing the adverse impact of injection drug use in Canada.

Kevin B Laupland1, John M Embil.   

Abstract

Year:  2012        PMID： 23997772      PMCID： PMC3476549          DOI： 10.1155/2012/297530

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  17 in total

1.  Public health understandings of policy and power: lessons from INSITE.

Authors:  Patrick Fafard
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

2.  Is Vancouver Canada's supervised injection facility cost-saving?

Authors:  Steven D Pinkerton
Journal:  Addiction       Date:  2010-08       Impact factor: 6.526

3.  Safer injection facility use and syringe sharing in injection drug users.

Authors:  Thomas Kerr; Mark Tyndall; Kathy Li; Julio Montaner; Evan Wood
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

4.  A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.

Authors:  Martin A Andresen; Neil Boyd
Journal:  Int J Drug Policy       Date:  2009-05-06

5.  How many HIV infections are prevented by Vancouver Canada's supervised injection facility?

Authors:  Steven D Pinkerton
Journal:  Int J Drug Policy       Date:  2011-03-29

6.  Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration.

Authors:  Mark Gilbert; Judy MacDonald; Dan Gregson; Jennifer Siushansian; Kunyan Zhang; Sameer Elsayed; Kevin Laupland; Tom Louie; Karen Hope; Michael Mulvey; John Gillespie; Diane Nielsen; Virginia Wheeler; Marie Louie; Agnes Honish; Gloria Keays; John Conly
Journal:  CMAJ       Date:  2006-06-27       Impact factor: 8.262

7.  Hospital utilization and costs in a cohort of injection drug users.

Authors:  A Palepu; M W Tyndall; H Leon; J Muller; M V O'Shaughnessy; M T Schechter; A H Anis
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

8.  Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population.

Authors:  Mark Gilbert; Judy Macdonald; Marie Louie; Dan Gregson; Kunyan Zhang; Sameer Elsayed; Kevin Laupland; Diane Nielsen; Virginia Wheeler; Tara Lye; John Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

9.  Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting.

Authors:  Kate Shannon; Thomas Kerr; Brandon Marshall; Kathy Li; Ruth Zhang; Steffanie A Strathdee; Mark W Tyndall; Julio G S Montaner; Evan Wood
Journal:  Arch Pediatr Adolesc Med       Date:  2010-01

10.  An appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite.

Authors:  Dan Small
Journal:  Harm Reduct J       Date:  2010-10-09
View more
  3 in total

1.  Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs.

Authors:  Christina E Freibott; Kristina T Phillips; Bradley J Anderson; Catherine Stewart; Jane M Liebschutz; Michael D Stein
Journal:  J Addict Med       Date:  2022 Mar-Apr 01       Impact factor: 3.702

2.  Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study.

Authors:  Lisa Lazarus; Sheetal Patel; Ashley Shaw; Sean Leblanc; Christine Lalonde; Manisha Hladio; Kira Mandryk; Cynthia Horvath; William Petrcich; Claire Kendall; Mark W Tyndall
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

3.  Risk environments facing potential users of a supervised injection site in Ottawa, Canada.

Authors:  Ashley Shaw; Lisa Lazarus; Tyler Pantalone; Sean LeBlanc; Dolly Lin; Daina Stanley; Caleb Chepesiuk; Sheetal Patel; Mark Tyndall
Journal:  Harm Reduct J       Date:  2015-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.